Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Amphotericin B Analogs Boast Lower Toxicity

Drug Discovery: Drugs based on new amphotericin B derivatives could have reduced side effects

by Stu Borman
June 4, 2015 | A version of this story appeared in Volume 93, Issue 23

Article:

This article has been sent to the following recipient: